32 min listen
Booster shots and pediatric vaccines with Dr. Peter Marks
FromMoving Medicine
ratings:
Length:
49 minutes
Released:
Dec 21, 2021
Format:
Podcast episode
Description
Peter Marks, MD, PhD, director of the Center for Biologics Evaluation and Research at the FDA, joins Susan R. Bailey, MD, immediate past president of the AMA, to discuss the data and recommendations for Pfizer, Moderna and Janssen booster shots. Dr. Marks walks through the safety and efficacy data supporting the recent authorization of the Pfizer pediatric vaccine for 5- to 11-year-old children.
This episode was part of an AMA webinar recorded prior to the emergence of the Omicron variant.? Follow the AMA on YouTube: @americanmedicalassociation
? Watch #AMAUpdate for the latest in health care news for physicians:
https://bit.ly/AMA_Update
? Subscribe to AMA Morning Rounds newsletter, with the news you need
every morning delivered to your inbox: https://bit.ly/AMA-MorningRounds
? Listen to our latest podcast episodes now:
https://bit.ly/AMA_Podcasts
? Download AMA Connect for news, podcasts, video updates and learning in
one place: https://apple.co/3URzNES
This episode was part of an AMA webinar recorded prior to the emergence of the Omicron variant.? Follow the AMA on YouTube: @americanmedicalassociation
? Watch #AMAUpdate for the latest in health care news for physicians:
https://bit.ly/AMA_Update
? Subscribe to AMA Morning Rounds newsletter, with the news you need
every morning delivered to your inbox: https://bit.ly/AMA-MorningRounds
? Listen to our latest podcast episodes now:
https://bit.ly/AMA_Podcasts
? Download AMA Connect for news, podcasts, video updates and learning in
one place: https://apple.co/3URzNES
Released:
Dec 21, 2021
Format:
Podcast episode
Titles in the series (100)
Advocacy Year-End Wrap Up, Part 1: In this episode, we listen in to the first half of the Council on Legislation forum at the 2018 AMA Interim Meeting. Willie Underwood III, M.D., David T. Tayloe Jr., M.D., Marilyn J. Heine, M.D., and Mary S. Carpenter, M.D., each discuss the AMA’s advocacy efforts on issues in 2018. by Moving Medicine